| Subject: | CDC Issues a Health Alert Against the Use of Amantadine and Rimandatine for the Treatment or Prophylazis of Influenza During the 2005-2006 Influenza Season |
| Category: | Centers for Disease Control and Prevention (CDC)
|
| Published: | Tue, 17 Jan 2006 - 10:00 am |
| The CDC has issued a Health Alert, dated January 14, 2006, against the use of Amantadine and Rimandatine for the treatment or prophylazis of Influenza during the 2005-2006 influenza season. Recent evidence indicates that a high proportion of currently circulating Influenza A viruses in this country are resistant to Amantadine and Rimandatine.
Amantadine is also used to treat the symptoms of Parkinson's disease, and should continue to be used for this indication.
On the basis of available... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
External Links:
Related MCN Products:
|
|
StayAlert!® Virtual Compliance Administrator™ keeps clients informed by email of any changes to Federal regulations, including Joint Commission (TJC, formerly JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG, and many more, and also provides downloadable tools to ensure compliance. StayAlert! is a premium product sold as an annual site-license subscription. With the site license, the client can sign up an unlimited number of users for the email alerts and access to the StayAlert! online regulatory library. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
